Category: 22246-04-4

Reference of 22246-04-4, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Article, and a compound is mentioned, 22246-04-4, 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery.

Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT1A receptor and the serotonin transporter

The structure-activity relationship (SAR) for three series of lactam-fused chroman derivatives possessing 3-amino substituents was evaluated. Many compounds exhibited affinities for both the 5-HT1A receptor and the 5-HT transporter. Compounds 45 and 53 demonstrated 5-HT1A antagonist activities in the in vitro cAMP turnover model.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Reference of 22246-04-4. In my other articles, you can also check out more blogs about 22246-04-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Synthetic Route of 22246-04-4, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.22246-04-4, Name is 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, molecular formula is C10H11NO2. In a Article£¬once mentioned of 22246-04-4

Inhibition of phenylethanolamine n-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4-tetrahydroisoquinolines: Further studies on the hydrophilic pocket of the aromatic ring binding region of the active site

In a continuation of studies directed toward characterizing the hydrophilic pocket within the aromatic ring binding region of the active site of phenylethanolamine N-methyltransferase (PNMT), 5-, 6-, 7-, and 8-hydroxy-1,2,3,4-tetrahydroisoquinoline were prepared and evaluated as substates and inhibitors of PNMT. In order to discern the necessity of an acidic hydrogen for interaction at this pocket the corresponding methyl ethers were also evaluated. The enhanced affinity of 7-hydroxy-1,2,3,4-tetrahydroisoquinoline (16) versus tetrahydroisoquinoline (13) itself indicates that a hydrophilic pocket exists off of carbon C7 in bound tetrahydroisoquinolines. The diminished affinity of the corresponding methyl ether is consistent with a requirement for the acidic hydrogen of 16 for interaction of the aromatic hydroxyl at site. From the relative activities of the other regioisomeric aromatic hydroxyl-substituted tetrahydroisoquinolines, their corresponding methyl ethers, and 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, it appears that the hydrophilic pocket is spatially compact with respect to bound tetrahydroisoquinolines and is surrounded by larger areas of lipophilic character. To allow a comparison of the results of this study with previous data on bound beta-phenylethylamines, the methyl ethers of 5-, 6-, 7-, and 8-hydroxy-exo-2-aminobenzonorbornene and of 5- and 6-hydroxy-anti-9-aminobenzonorbornene were also evaluated for their activity as substrates and inhibitors for PNMT. The results of this study are in agreement with previous findings for bound beta-phenylethylamines and support the conclusion that the natural substrate for PNMT, norepinephrine, has a different active site binding orientation than most known substrates and competitive inhibitors of the enzyme.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 22246-04-4, and how the biochemistry of the body works.Synthetic Route of 22246-04-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 22246-04-4, name is 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery. HPLC of Formula: C10H11NO2

USE OF SUBSTITUTED ISOQUINOLINONES, ISOQUINOLINDIONES, ISOQUINOLINTRIONES AND DIHYDROISOQUINOLINONES OR IN EACH CASE SALTS THEREOF AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS

Use of substituted isoquinolinones, isoquinolinediones, isoquinolinetriones and dihydroisoquinolinones of the general formula (I) or their respective salts where the radicals in the general formula (I) correspond to the definitions given in the description, for enhancing stress tolerance in plants to abiotic stress, for strengthening plant growth and/or for increasing plant yield, and selected processes for preparing the compounds mentioned above.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 22246-04-4, and how the biochemistry of the body works.HPLC of Formula: C10H11NO2

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Related Products of 22246-04-4, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Article, and a compound is mentioned, 22246-04-4, 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery.

Light-Driven Intramolecular C?N Cross-Coupling via a Long-Lived Photoactive Photoisomer Complex

Reported herein is a visible-light-driven intramolecular C?N cross-coupling reaction under mild reaction conditions (metal- and photocatalyst-free, at room temperature) via a long-lived photoactive photoisomer complex. This strategy was used to rapidly prepare the N-substituted polycyclic quinazolinone derivatives with a broad substrate scope (>50 examples) and further exploited to synthesize the natural products tryptanthrin, rutaecarpine, and their analogues. The success of gram-scale synthesis and solar-driven transformation, as well as promising tumor-suppressing biological activity, proves the potential of this strategy for practical applications. Mechanistic investigations, including control experiments, DFT calculations, UV-vis spectroscopy, EPR, and X-ray single-crystal structure of the key intermediate, provides insight into the mechanism.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 22246-04-4. In my other articles, you can also check out more blogs about 22246-04-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Electric Literature of 22246-04-4, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 22246-04-4, Name is 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, molecular formula is C10H11NO2. In a Patent£¬once mentioned of 22246-04-4

4-SUBSTITUTED 4, 6-DIALKOXY-CINNOLINE DERIVATIVES AS PHOSPODIESTERASE 10 INHIBITORS FOR THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL SYNDROMS

The present disclosure relates generally to the field of phosphodiesterase 10 (PDE10) enzyme inhibition by cinnoline compounds of Formulas:(I) and (II); wherein R’-R3 and R15 -R18 are as defined herein. Still further, the present invention provides methods for synthesizing compounds with such activity and selectivity, as well as methods of and corresponding pharmaceutical compositions for treating a patient, e.g., mammals, including humans, in need of PDE inhibition. Treatment is preferably for a disease state that involves elevated intracellular PDE10 levels or decreased cAMP and/or cGMP levels, e.g., involving neurological or psychiatric syndromes, especially those states associated with psychoses, most especially schizophrenia or bipolar disorder, obsessive-compulsive disorder, and/or Parkinson’s disease. In particular, such psychoses, obsessive-compulsive disorder, and/or Parkinson’s disease arc due at least in part to catabolism of intracellular cAMP and/or cGMP levels by PDE 10 enzymes or where such an impaired condition can be improved by increasing cAMP and/or cGMP levels

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Electric Literature of 22246-04-4. In my other articles, you can also check out more blogs about 22246-04-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, SDS of cas: 22246-04-4, such as the rate of change in the concentration of reactants or products with time.In a article, mentioned the application of 22246-04-4, Name is 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one, molecular formula is C10H11NO2

FLUOROALLYLAMINE DERIVATIVE AND USE THEREOF

The present invention relates to a fluoroallylamine derivative and use thereof. In particular, the present invention relates to a compound as shown in Formula I, a prodrug, an isomer, an isotope-labeled compound, a solvate or a pharmaceutically acceptable salt thereof, which has VAP-1/SSAO inhibitory activity, and can be used for treating a disease associated with VAP-1/SSAO overactivity.

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, SDS of cas: 22246-04-4, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 22246-04-4

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

22246-04-4, 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Step 3: Synthesis of 7-methoxy- 1,2,3, 4-Tetrahydro-isoquinoline; To a slurry of lithium aluminium hydride (2.42 g, 63.56 mmol) in dry tetrahydrofuran at 0 C was added 3,4-dihydro-7-methoxyisoquinolin-l(2H)-one (4.5 g, 25.4 mmol) dissolved in tetrahydrofuran and the solution refluxed for 2 h with stirring. Reaction mixture was quenched at 0 C with water (2.5 mL), 10% sodium hydroxide solution (2.5 mL) and water (7.5 mL). The stirring was continued at room temperature for 30 min. It was filtered through a celite bed which was thoroughly washed with CHCl3 (-100 mL). The CHCl3 was concentrated under reduced pressure to give crude material (2.9 g, 70 %) which was used as such for next step. ESIMS (m/z): 186.0 (M+Na), 164.1 (M+l), 22246-04-4

The synthetic route of 22246-04-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; PANACEA BIOTEC LIMITED; WO2009/118765; (2009); A2;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

22246-04-4, 7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example IX: Synthesis of l-(7-butoxy-2-isopropyl-l,2,3,4-tetrahydro-isoquinoIin-4- yl)-cyclohexanol; Step 1: Synthesis of 2-isopropyl-7-methoxy-3,4-dihydro-2H-isoquinolin-l-one; To a slurry of sodium hydride (671 mg, 27.97 mmol) in tetrahydrofuran (5 mL) was added 7-methoxy-3,4-dihydro-2/J-isoquinolin-l-one, obtained in example IV (step 2), in tetrahydrofuran (5 ml) and isopropyl iodide (1.40 ml, 13.98 mmol). The reaction mixture was stirred for 1 h at 80 0C. The reaction mixture was quenched with water (15 mL) and extracted with EtOAc (3×30 mL). The combined organic layer was washed with water (2×30 mL) and brine (30 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to give crude material which was purified by column chromatography (silica gel, 2:98 MeOH : CHCl3) to yield the title compound (1.62 g, 79 %) as viscous liquid.ESIMS (m/z): 219.3 (M+l), 22246-04-4

The synthetic route of 22246-04-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; PANACEA BIOTEC LIMITED; WO2009/118765; (2009); A2;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.22246-04-4,7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one,as a common compound, the synthetic route is as follows.

To a solution of 31.25g(0.29 mol) of sodium hydride in 50 mL of dry N,N-dimethylformamide a solution of 11.50 g (65.0 mmol) 7-methoxy-3,4-dihydroisoquinolin-1(2H)-onein 30 mL of N,N-dimethylformamideand 10.15g (71.5mmol) iodomethane was added dropwise under ice-cooling. The reaction mixture was stirred at room temperature (20C) for 1.5 hrs. The reaction was quenched with 480ml water,extracted with ethyl acetate (100 mL x 3), washed with brine,and dried over Na2SO4.The organic phase was evaporated under reduced pressure togivecrude oil.The residue was purified withcolumn chromatography (eluent: ethyl acetate : hexane = 1 : 5) to afford yellowoil(11.17 g, 58.5mmol, 90% yield)., 22246-04-4

As the paragraph descriping shows that 22246-04-4 is playing an increasingly important role.

Reference£º
Article; Dou, Fei; Cao, Xudong; Jing, Peng; Wu, Chunyan; Zhang, Yuxin; Chen, Yin; Zhang, Guisen; Bioorganic and Medicinal Chemistry Letters; vol. 29; 12; (2019); p. 1492 – 1496;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.22246-04-4,7-Methoxy-3,4-dihydroisoquinolin-1(2H)-one,as a common compound, the synthetic route is as follows.

0.2 mol sodium hydroxide was dissolved in 200ml N,N-dimethyl formamide, then the oil (0.1 mol) prepared instep (2) was added, The reaction was stirred in ice bath for 0.5 hour, and then iodomethane (0.15 mol) was slowlyadded dropwise. After the addition was completed, the reaction was conducted at room temperature for 10 hours.After the reaction was completed, the reaction solution was poured into 1 L ice water to terminate the reaction.Extraction with ethyl acetate was conducted. The organic layer was washed with saturated saline solution, driedover anhydrous magnesium sulfate. The solvent was removed by rotary evaporateion to give 17.8 g of brown solid.Yield: 93%.MS (ESI) m/z 191.1 ([M+H]+), 22246-04-4

The synthetic route of 22246-04-4 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; NHWA Pharma Corporation; CHEN, Yin; DOU, Fei; QIU, Yinli; YU, Minquan; ZHANG, Guisen; (42 pag.)EP3381915; (2018); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem